1-17 of 17
Martin Mistrik, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (RD) in RRMM Patients Treated in Routine Clinical Practice: Results from the Czech Registry of Monoclonal Gammopathies (RMG)

Jiri Minarik, MD PhD, Tomas Pika, MD PhD, Jakub Radocha, Alexandra Jungova, Jan Straub, MD, Tomas Jelinek, MD, Ludek Pour, MD, Petr Pavlicek, MD, Martin Mistrik, MD PhD, Lucie Brožová, MSc, Petra Krhovska, Katerina Machalkova, Pavel Jindra, MD PhD, Ivan Spicka, MD PhD Prof, Hana Plonkova, MD, Martin Stork, MD, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, MD, Lukáš Stejskal, MD, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, MD, Vladimir Maisnar, MD PhD MBA, Roman Hajek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3139.
https://doi.org/10.1182/blood-2019-128865
Published: 2019
Journal Articles

Whole Exome Sequencing of Residual Disease in Multiple Myeloma: Searching for Novel Therapeutic Targets

Martina Zátopková, MSc, Tereza Sevcikova, Zuzana Kufova, Katerina Growkova, Jana Filipova, Tomas Jelinek, Lucie Říhová, Renata Bezděková, MSc., Fedor Kryukov, Jana Smejkalová, Jiri Minarik, MD PhD, Vladimir Maisnar, MD, Martin Mistrik, MD PhD, Ludek Pour, MD, Alexandra Jungova, Michal Šimíček, Giovanni Stracquadanio, Roman Hajek
Journal: Blood
Blood (2018) 132 (Supplement 1): 3175.
https://doi.org/10.1182/blood-2018-99-112611
Published: 2018
Journal Articles

Treatment of Relapsed and Refractory Multiple Myeloma with Fully Oral Triplet IRD (ixazomib, lenalidomide and dexamethasone) Is Safe and with Significant Therapeutic Outcomes

Jiri Minarik, MD PhD, Petra Krhovska, Tomas Jelinek, Alexandra Jungova, Martin Mistrik, MD PhD, Tomas Pika, MD PhD, Evzen Gregora, MD, Vladimir Maisnar, MD, Jan Straub, MD, Ludek Pour, MD, Lucie Brozova, MSc, Jaroslav Bacovsky, Hana Plonkova, Pavel Jindra, MD PhD, Petr Pavlicek, MD, Jakub Radocha, MD, Ivan Spicka, MDPhDProf, Martin Stork, MD, Vlastimil Scudla, Prof, MD CSc, Roman Hajek
Journal: Blood
Blood (2018) 132 (Supplement 1): 1959.
https://doi.org/10.1182/blood-2018-99-112046
Published: 2018
Journal Articles

Treatment Outcomes in Patients Treated with Tyrosine Kinase Inhibitors in "Slovak Registry of Chronic Myeloid Leukemia" (CAMELIA SK)

Zuzana Sninska, MD PhD, Martin Mistrik, MD PhD, Ass. Prof., Katarina Slezakova, MD PhD, Ludmila Demitrovicova, MD, Eva Mikuskova, MD PhD, Imrich Markuljak, MD, Juraj Chudej, MD PhD, Natalia Stecova, MD, Elena Tothova, Prof, MD PhD, Adriana Kafkova, MD PhD, Stanislav Palasthy, MD, Jana Lesko-Andrascikova, MD, Tereza Necasova, Bc, Eva Koritakova, RNDr
Journal: Blood
Blood (2016) 128 (22): 3087.
https://doi.org/10.1182/blood.V128.22.3087.3087
Published: 2016
Journal Articles

Effectiveness of Lenalidomide and Dexamethasone for the Treatment of Extramedullary Plasmacytoma in Patients with Multiple Myeloma: Report of Two Cases

Katarína Masárová, MD, Zdenka Stefanikova, MD, Martin Mistrik, MD PhD, Ass. Prof., Angelika Batorova, MD PhD Ass. Prof.
Journal: Blood
Blood (2014) 124 (21): 5760.
https://doi.org/10.1182/blood.V124.21.5760.5760
Published: 2014
Journal Articles

Optimal Use of Granulocyte Colony Stimulating Factor (G-CSF) after Autologous Hematopoietic Stem Cell Transplantation

Firas Al Sabty, MD PhD, Martin Mistrik, MD PhD, Ass. Prof., MikulᚠHrubiško, MD PhD, Prof., Eva Bojtárová, MD PhD, Ján Martinka, MD, Angelika Batorova, MD PhD Ass. Prof.
Journal: Blood
Blood (2014) 124 (21): 2519.
https://doi.org/10.1182/blood.V124.21.2519.2519
Published: 2014
Journal Articles

High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of High Dose AraC

Roelof Willemze, MD, PhD, Stefan Suciu, Franco Mandelli, MD, Giovanna Meloni, Boris Labar, Stijn J.M. Halkes, Petra Muus, MD, PhD, Martin Mistrik, MD, PhD, Giorgina Specchia, Francesco Fabbiano, MD, Francesco Nobile, MD, Marco Sborgia, Andrea Camera, Dominik Selleslag, Francois Lefrere, Domenico Magro, MD, Giuseppe Leone, Nicola Cantore, Meral Beksac, MD, Zwi Berneman, Xavier Thomas, Lorella Melillo, Dominique Bron, Georges Fillet, Jose E. Guimaraes, MD, PhD, Sergio Amadori, Paola Fazi, Matthias Karrasch, Marco Vignetti, Theo de Witte, Jean-Pierre Marie, MD
Journal: Blood
Blood (2011) 118 (21): 257.
https://doi.org/10.1182/blood.V118.21.257.257
Published: 2011
Journal Articles

High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of Low Dose IL-2 Maintenance,

Roelof Willemze, MD, PhD, Stefan Suciu, Franco Mandelli, MD, Stijn J.M. Halkes, Jean-Pierre Marie, Boris Labar, Adriano Venditti, M.D., Petra Muus, MD, PhD, Martin Mistrik, MD, PhD, Andrea Camera, Domenico Magro, MD, Lorella Melillo, Dominique Bron, Silvana Magrin, Dominik Selleslag, Domenico Pastore, Silvia Trisolini, Paola Fazi, Matthias Karrasch, Marco Vignetti, Sergio Amadori, MD, Theo M. de Witte, MD, Giovanna Meloni, MD
Journal: Blood
Blood (2011) 118 (21): 3612.
https://doi.org/10.1182/blood.V118.21.3612.3612
Published: 2011
Journal Articles

Two Strategies of Stem Cells Mobilization Using Plerixafor and Comparison of Grafts Obtained with and without It. Is Plerixafor Only a Mobilization Agent?

Michal Zwiewka, MD, Zdenka Stefanikova, MD, Katarína Masárová, MD, Ján Martinka, MD, Mikuláš Hrubiško, MD, PhD., Hana Pribulová, Mgr., Jolana Hapalová, RNDr., Eva Bojtárová, MD, PhD., Martin Mistrik, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4385.
https://doi.org/10.1182/blood.V118.21.4385.4385
Published: 2011
Journal Articles

Treatment of Consecutive Patients with Chronic Myeloid Leukemia In the Cooperating Centers From the Slovak Republic After 2000 – A Report From the Population Based CAMELIA Registry

Eva Demeckova, Martin Mistrik, MD, PhD, Ludmila Demitrovicova, Juraj Chudej, MD, Imrich Markuliak, Elena Tothova, Jan Muzik, MSci, PhD, Ladislav Dusek
Journal: Blood
Blood (2011) 118 (21): 4439.
https://doi.org/10.1182/blood.V118.21.4439.4439
Published: 2011
Journal Articles

Is Standard Treatment (DA 3+7) Is Still Recommended As Front Line Therapy for Adult Patients with De Novo AML? the Role of Etoposide

Firas Al Sabty, MD, PhD, Eva Demeckova, Ladislav Sopko, Eva Weismanova, Martin Mistrik, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4272.
https://doi.org/10.1182/blood.V118.21.4272.4272
Published: 2011
Journal Articles

Value of Low Dose IL-2 as Maintenance Following Consolidation Treatment or Autologous Transplantation in Acute Myelogenous Leukemia (AML) Patients Aged 15-60 Years Who Reached CR After High Dose (HD-AraC) Vs Standard Dose (SD-AraC) Cytosine Arabinoside During Induction: Results of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups.

Roelof Willemze, MD, PhD, Stefan Suciu, Franco Mandelli, MD, Stijn J.M. Halkes, MD, PhD, Jean-Pierre Marie, MD, Boris Labar, MD, PhD, Adriano Venditti, MD, Petra Muus, MD, PhD, Martin Mistrik, MD, PhD, Bruno Rotoli, Domenico Magro, Lorella Melillo, Dominique Bron, Francesco Fabbiano, Dominik L.D. Selleslag, MD, Domenico Pastore, Silvia maria Trisolini, Paola Fazi, Christelle Vandermaelen, Liliana Baila, Marco Vignetti, Sergio Amadori, T. M. de Witte, Giovanna Meloni
Journal: Blood
Blood (2009) 114 (22): 791.
https://doi.org/10.1182/blood.V114.22.791.791
Published: 2009
Journal Articles

Upregulation of HLA-G Gene Expression in Malignant Hematopoietic Cells Treated with 5-Aza-2′- Ddeoxycytidine.

Firas Alsabty, Martin Mistrik, MD, PhD, Katarina Polakova
Journal: Blood
Blood (2009) 114 (22): 4567.
https://doi.org/10.1182/blood.V114.22.4567.4567
Published: 2009
Journal Articles

High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SDAraC) during Induction and Value of IL-2 during Maintenance in Acute Myelogenous Leukemia (AML): Impact of AraC Dose on Complete Remission Rate and Toxicity (Results on the first 1700 randomized patients of the AML-12 trial of EORTC and GIMEMA Leukemia Groups)

Roelof Willemze, MD, PhD, Stefan Suciu, Franco Mandelli, Boris Labar, MD, PhD, Jean-Pierre Marie, Martin Mistrik, MD, PhD, Vincenzo Liso, Francesco Fabbiano, Francesco Nobile, Marco Sborgia, Bruno Rotoli, Dominik L.D. Selleslag, MD, Francois Lefrere, Sr., MD, Antonio Peta, Massimo F Martelli, Giuseppe Leone, Nicola Cantore, Meral Beksac, Zwi Berneman, Xavier Thomas, Michele Mario Greco, Dominique Bron, Georges Fillet, Jose E. Guimaraes, MD, PhD, Petra Muus, Paola Fazi, Liliana Baila, Marco Vignetti, Sergio Amadori, Theo de Witte on behalfhe European Group for Blood Marrow Transplantation, Giovanna Meloni
Journal: Blood
Blood (2008) 112 (11): 134.
https://doi.org/10.1182/blood.V112.11.134.134
Published: 2008
Journal Articles

Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.

Roman Hajek Prof, MD, Ivan Spicka, MD, PhD, Vlastimil Scudla, MD, Evzen Gregora, MD, Vladimir Maisnar, MD, PhD, Miroslava Schutzova, MD, Elena Tothova Prof, MD, Martin Mistrik, MD, PhD, Marta Krejci, MD, PhD, Jan Straub, MD, Jiri Minarik, MD, Jakub Radocha, MD, Vladimir Koza, MD, PhD, Petr Pavlicek, MD, Libuse Novosadova, MD, Hana Frankova, MD, Yvetta Stavarova, MD, Petr Kessler, MD, Lenka Walterova, MD, Jaromir Gumulec, MD, Adam Svobodnik, PhD, Dana Kralova, Zdenek Adam, MD
Journal: Blood
Blood (2007) 110 (11): 531.
https://doi.org/10.1182/blood.V110.11.531.531
Published: 2007
Journal Articles

Genetic and Phenotypic Analysis of Families with Inherited Hypo- and Dys-Fibrinogenemia. Fibrinogen Bratislava.

Angelika Batorova, MD, PhD, Daniela Horvathova, MD, Martin Mistrik, MD, PhD, Philippe de Moerloose, MD, PhD, Marguerite Neerman-Arbez, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1794.
https://doi.org/10.1182/blood.V106.11.1794.1794
Published: 2005
Journal Articles

A Multi-Institutional Study of Extracorporeal Photoimmune Therapy with UVADEX® for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation.

Paul J. Shaughnessy, MD, Brian J. Bolwell, MD, Sunil Abhyankar, MD, Koen van Besien, MD, Martin Mistrik, MD PhD, Andrew Grigg, MBBS, Anthony Dodds, MBBS, H. Miles Prince, MBBS, Alexandra Machado, MD, Ulrich Thienel, MD, PhD, Jim Wang, Francine Foss, MD, Jane Apperley, MBChB
Journal: Blood
Blood (2004) 104 (11): 1230.
https://doi.org/10.1182/blood.V104.11.1230.1230
Published: 2004